Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04181203
Title Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (CARLHA-2)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors UNICANCER
Indications

prostate adenocarcinoma

Therapies

Gonadorelin + Radiotherapy

Apalutamide + Gonadorelin + Radiotherapy

Age Groups: senior | adult
Covered Countries


No variant requirements are available.